skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 125  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Vaccines remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effectiveness of maternal pertussis vaccination in England: an observational study
Material Type:
Article
Add to My Research

Effectiveness of maternal pertussis vaccination in England: an observational study

The Lancet (British edition), 2014-10, Vol.384 (9953), p.1521-1528 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright Elsevier Limited Oct 25, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)60686-3 ;PMID: 25037990 ;CODEN: LANCAO

Full text available

2
Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study
Material Type:
Article
Add to My Research

Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study

Nature communications, 2022-09, Vol.13 (1), p.5736-5736, Article 5736 [Peer Reviewed Journal]

Crown 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-33378-7

Full text available

3
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study
Material Type:
Article
Add to My Research

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

The Lancet infectious diseases, 2018-04, Vol.18 (4), p.441-451 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 1, 2018 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(18)30052-5 ;PMID: 29395999

Full text available

4
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
Material Type:
Article
Add to My Research

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

The Lancet (British edition), 2016-12, Vol.388 (10061), p.2775-2782 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 3, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31921-3 ;PMID: 28100432 ;CODEN: LANCAO

Full text available

5
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England
Material Type:
Article
Add to My Research

Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England

Nature medicine, 2022-04, Vol.28 (4), p.831-837 [Peer Reviewed Journal]

2022. Crown. ;Crown 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Crown 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-01699-1 ;PMID: 35045566

Full text available

6
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Material Type:
Article
Add to My Research

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

BMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964

Full text available

7
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Material Type:
Article
Add to My Research

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

New England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274

Digital Resources/Online E-Resources

8
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
Material Type:
Article
Add to My Research

Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study

The Lancet infectious diseases, 2023-04, Vol.23 (4), p.435-444 [Peer Reviewed Journal]

2023 ;Crown Copyright © 2023 Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright Elsevier Limited Apr 2023 ;Crown Copyright © 2022 Published by Elsevier Ltd. 2023 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00729-0 ;PMID: 36436536

Full text available

9
Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England
Material Type:
Article
Add to My Research

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England

The New England journal of medicine, 2020-01, Vol.382 (4), p.309-317 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1901229 ;PMID: 31971676

Full text available

10
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
Material Type:
Article
Add to My Research

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

New England Journal of Medicine, 2022-01, Vol.386 (4), p.340-350 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2115481 ;PMID: 35021002

Digital Resources/Online E-Resources

11
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
Material Type:
Article
Add to My Research

Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England

Nature communications, 2021-12, Vol.12 (1), p.7217-7217, Article 7217 [Peer Reviewed Journal]

2021. Crown. ;Crown 2021. corrected publication 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Crown 2021, corrected publication 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-27410-5 ;PMID: 34893611

Full text available

12
Effectiveness of BNT162b2 against COVID-19 in adolescents
Material Type:
Article
Add to My Research

Effectiveness of BNT162b2 against COVID-19 in adolescents

The Lancet infectious diseases, 2022-05, Vol.22 (5), p.581-583 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Published by Elsevier Ltd. 2022 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00177-3 ;PMID: 35325619

Full text available

13
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia
Material Type:
Article
Add to My Research

Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia

The New England journal of medicine, 2020-01, Vol.382 (4), p.318-327 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1900236 ;PMID: 31971677

Full text available

14
Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK
Material Type:
Article
Add to My Research

Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK

The Lancet infectious diseases, 2021-04, Vol.21 (4), p.e93-e102 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30492-8 ;PMID: 33129426

Full text available

15
Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004–11: an observational study
Material Type:
Article
Add to My Research

Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004–11: an observational study

The Lancet infectious diseases, 2014-04, Vol.14 (4), p.301-307 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 2014 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(13)70332-3 ;PMID: 24508198 ;CODEN: LANCAO

Full text available

16
The changing and dynamic epidemiology of meningococcal disease
Material Type:
Article
Add to My Research

The changing and dynamic epidemiology of meningococcal disease

Vaccine, 2012-05, Vol.30, p.B26-B36 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2011.12.032 ;PMID: 22178525

Full text available

17
Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016
Material Type:
Article
Add to My Research

Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016

Emerging infectious diseases, 2019-09, Vol.25 (9), p.1708-1718 [Peer Reviewed Journal]

COPYRIGHT 2019 U.S. National Center for Infectious Diseases ;COPYRIGHT 2019 U.S. National Center for Infectious Diseases ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2509.180747 ;PMID: 31441745

Full text available

18
Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England
Material Type:
Article
Add to My Research

Effectiveness of ChAdOx1-S COVID-19 booster vaccination against the Omicron and Delta variants in England

Nature communications, 2022-12, Vol.13 (1), p.7688-7688 [Peer Reviewed Journal]

2022. Crown. ;Crown 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Crown 2022 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-022-35168-7 ;PMID: 36509743

Full text available

19
Should the UK introduce a universal childhood varicella vaccination programme?
Material Type:
Article
Add to My Research

Should the UK introduce a universal childhood varicella vaccination programme?

Archives of disease in childhood, 2016-01, Vol.101 (1), p.2-3 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;ISSN: 0003-9888 ;EISSN: 1468-2044 ;DOI: 10.1136/archdischild-2015-308730 ;PMID: 26342095 ;CODEN: ADCHAK

Full text available

20
Measles: the legacy of low vaccine coverage
Material Type:
Article
Add to My Research

Measles: the legacy of low vaccine coverage

Archives of disease in childhood, 2013-10, Vol.98 (10), p.752-754 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2014 INIST-CNRS ;Copyright: 2013 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-9888 ;EISSN: 1468-2044 ;DOI: 10.1136/archdischild-2013-304292 ;PMID: 23898160 ;CODEN: ADCHAK

Full text available

Results 1 - 20 of 125  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1999  (6)
  2. 1999 To 2004  (11)
  3. 2005 To 2011  (21)
  4. 2012 To 2018  (34)
  5. After 2018  (54)
  6. More options open sub menu

Searching Remote Databases, Please Wait